DIRS.INFO The most relevant business & tech news

“Zero chance.”“Just four years ago we had the signing of the historic Abraham Accords, and today we have an attack on Israel,” he said. Senior members of Hamas said that Iranian security officials helped them plan the attack and gave it their blessing last week. According to the State Department, Iran provides roughly $100 million a year to Palestinian militia groups like Hamas. “Israel is now paying the price for those policies.”He also blasted Biden for “sleeping on the job.”"I saw the president's comments with respect to the attacks on Israel. America needs to wake up.”The Hamas attack caught Israeli defense systems off guard and is being characterized by officials as a catastrophic intelligence failure.

Persons: Joe Biden, Joe Biden’s, Donald Trump, “, ” “, Abraham, ”, Trump, Biden, Ron DeSantis, ” DeSantis, hasn’t, Joe Biden's, You’ve, you’ve, DeSantis, Benjamin Netanyahu, Nikki Haley, Haley, NBC’s Kristen Welker, America’s, ” Haley, they’re, Vivek Ramaswamy, Sen, Tim Scott of, Ramaswamy Organizations: Hamas, GOP, Abraham Accords, United Arab, U.S, White, UAE, Republican Party, Trump, State Department, White House National Security Council, Florida Gov, Israeli, United Nations, “, Press, Israel Locations: Israel, United Arab Emirates, Bahrain, Iran, U.S, South Korea, Qatar, Iowa, Florida, South Carolina, Gaza, Mexico, Israel’s, America, Tim Scott of South Carolina

☆ Iran prisoner swap for $6 billion in spotlight after Hamas attacks Israel
▼ + stars: | 2023-10-09 | by ( ) www.reuters.com time to read: +4 min

U.S. Secretary of State Antony Blinken said on Sunday that Iran has not yet been able to spend a single dollar of the $6 billion in funds that were unfrozen in a U.S.-Iran prisoner swap in September. WHAT WAS THE IRAN PRISONER SWAP DEAL? Five U.S. citizens detained by Tehran were allowed to leave the country in exchange for the transfer of $6 billion in Iranian funds that had been frozen in South Korea. The $6 billion was Iranian money that had been frozen in South Korean banks. Under the terms of the Iran prisoner deal, the money can only be used for humanitarian-related purposes, including purchasing food or other goods outside Iran for import, U.S. officials said.

Persons: Amir Cohen, Antony Blinken, Blinken, there’s, Joe Biden, Donald Trump, CNN's, Brian Nelson, we've, Nikki Haley, Heather Timmons, Idrees Ali, Lisa Shumaker Organizations: REUTERS, Rights, Israel, After Washington, State Department, South, Republican, Reuters, Thomson Locations: Gaza, Ashkelon, Israel, Iran, U.S, IRAN, Tehran, South Korea, United States, After, Seoul, Doha, South Carolina

☆ New weight loss drugs could mean a $25 billion drag on restaurants by 2025, says Mizuho's Dan Dolev
▼ + stars: | 2023-10-03 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailNew weight loss drugs could mean a $25 billion drag on restaurants by 2025, says Mizuho's Dan DolevMatt Taylor, Jefferies analyst, and Dan Dolev, managing director at Mizuho Securities, join 'The Exchange' to discuss how new weight loss drugs could decline revenue for restaurant transaction platforms Toast Tab, and how weight loss drugs could reduce the need for medical devices.

Persons: Dan Dolev Matt Taylor, Dan Dolev Organizations: Jefferies, Mizuho Securities

☆ Will weight loss drugs lead to less food consumption? Here's what Walmart is saying
▼ + stars: | 2023-09-27 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +5 min

While there has been a huge gain, it is barely scratching the surface of the potential market. Some potential patients don't have coverage of the pricey medicines through their health insurance plans yet. (For example, those seeking to use GLP-1 drugs for obesity can't receive coverage if they are insured by Medicare as the federal health plan is not allowed to cover weight loss drugs.) Walmart told Bank of America that fiscal second-quarter sales benefited roughly 1% from GLP-1 drug sales volumes. Its stock has fallen 45% year to date on fears that these drugs will shrink the company's market potential.

Persons: John Rainey, Eli Lilly's Mounjaro, Eli Lilly, Morgan Stanley, Wells, Larry Biegelsen, Biegelsen, Daniel Lyons, Janus Henderson, Lyons, — CNBC's Michael Bloom Organizations: Wall Street, Nordisk's Wegovy, Bank of, Walmart, Health, Novo Nordisk, Medicare, Drug, Bank of America, Janus, Janus Henderson Investors, CNBC Locations: U.S, GLP

☆ Dr. Scott Gottlieb: The challenge with A.I. tools is getting it regulated by FDA as medical devices
▼ + stars: | 2023-09-25 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailDr. Scott Gottlieb: The challenge with A.I. tools is getting it regulated by FDA as medical devicesFormer FDA commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss the integration of A.I. into health care, how the technology can alter the industry, and more.

Persons: Scott Gottlieb Organizations: FDA

☆ US government shutdown: What is it and who would be affected?
▼ + stars: | 2023-09-21 | by ( ) www.reuters.com time to read: +7 min

Contracts awarded prior to the shutdown would continue, and the Pentagon could place new orders for supplies or services needed to protect national security. NATIONAL PARKS AND NATURAL RESOURCESIt's not clear how the United States' 63 national parks would be affected. They remained open during the 2018-2019 shutdown, through restrooms and information desks were closed and waste disposal was halted. WHITE HOUSEIn 2018-2019 shutdown, the White House furloughed 1,100 of 1,800 staff in the Executive Office of the President. Some offices, such as the National Security Council, continued at full strength, while others like the Office of Management and Budget were scaled back sharply.

Persons: Kevin Wurm, Lockheed Martin, Donald Trump, Pete Buttigieg, Pell, Andy Sullivan, Pete Schroeder, Howard Schneider, Moira Warburton, Scott Malone, Alistair Bell Organizations: U.S, Capitol, REUTERS, Workers, Pentagon, Boeing, Lockheed, Raytheon, The, National Nuclear Security Administration, FBI, Drug Enforcement Administration, Service, Border Patrol, Coast Guard, Federal Trade, AFFAIRS U.S, National Institutes of Health, National Science Foundation, National Oceanographic, Atmospheric Administration, NASA, Space, Disease Control, Prevention, Food and Drug Administration, Securities, Exchange, Commodities, Futures Trading, Federal Reserve, Federal Deposit Insurance Corporation, Currency, Social Security Administration, Veterans Administration, Federal Emergency Management Agency, Education Department, White, Small Business Administration, National Labor Relations, National Security Council, Management, U.S . Postal, Thomson Locations: Washington , U.S, United States

NEW YORK, Sept 18 (Reuters) - A detainee swap that secured the release of five Americans held in Iran on Monday does not change Washington's adversarial relationship with Tehran, although the door remains open for diplomacy over the Islamic Republic's nuclear program, a senior administration official said. Even so, they said the door for diplomacy over Iran's nuclear program was not entirely shut. It was unclear if the official meant to deny any indirect talks, or if he was deliberately leaving the door open for them. After taking office in January 2021, U.S. President Joe Biden tried to revive the 2015 Iran nuclear deal under which Iran had restricted its nuclear program in return for relief from U.S., European Union and U.N. sanctions. However, earlier this year Washington and Tehran began exploring what analysts describe as "understandings" - which Washington has never acknowledged - to lower tensions over nuclear and other issues.

Persons: Washington, Mahmoud Ahmadinejad, Joe Biden, Donald Trump, Humeyra Pamuk, Stephen Coates Organizations: Biden, The U.S, United Nations General Assembly, Union, U.S, Republican, Iran, Thomson Locations: Iran, Tehran, United States, Qatar, The, Yemen, New York, U.S, Washington, South Korea, Doha

☆ An FDA advisory group confirmed some popular decongestants are ineffective. Now what do we do?
▼ + stars: | 2023-09-15 | by ( Madeline Holcombe | ) edition.cnn.com time to read: +6 min

It is safe to use, but an independent advisory committee to the FDA agreed Tuesday that it is ineffective in pill form. But before then, there are things you can do at home to help relieve your symptoms, he said. Warm compresses, hot showers and hydrationNoses like to be hydrated and warm, Brodner said. But steam from a hot shower or a warm compress placed over your nose can also heat things up nicely. That runny nose will help drain mucus from your sinuses — and hopefully flush out whatever is irritating it, Brodner said.

Persons: ”, David C, “ You’ll, ” Phenylephrine, Brodner, guaifenesin, Richard J, Harvey, Shanna Miko, you’re, ” Brodner, Stephen Rennard, Larson, Rennard, “ Organizations: CNN, Food and Drug Administration, FDA, Macquarie University, Epidemic Intelligence, US Centers for Disease Control, CDC, Medicine, University of Nebraska Medical Center Locations: Boynton Beach , Florida, Omaha

[1/2] Chairman and CEO of Vietnam's leading tech firm FPT Truong Gia Binh poses during an interview with Reuters at the company's headquarters in Hanoi, Vietnam September 11, 2023. REUTERS/Francesco Guarascio Acquire Licensing RightsHANOI, Sept 14 (Reuters) - Vietnam's leading tech firm FPT (FPT.HM) has orders for nearly 70 million chips through 2025 and is eyeing expansion in Artificial Intelligence (AI) and technical training, the company's chief said. It offers AI, cloud and big data services to clients in 29 countries and is also growing in chip designing and education. FPT sealed a partnership with U.S. firm Landing AI to boost its training capabilities, the company said. The new law was a "game-changer" because it created the conditions for foreign countries, "other than China", to expand, and U.S. pledges this week to boost Vietnam's chips sector further confirmed that, he said.

Persons: Gia Binh, Francesco Guarascio, FPT, Joe Biden's, Truong Gia Binh, Binh, Francesco Guarascio @fraguarascio, Phuong Nguyen, Lincoln Organizations: Reuters, REUTERS, Rights, Artificial Intelligence, U.S, Nvidia, Samsung, JPMorgan, Thomson Locations: Hanoi, Vietnam, Rights HANOI, Chi Minh City, Moscow, U.S, China, Taiwan, South Korea, Japan, Korean, United States

☆ Johnson & Johnson is getting rid of its script logo after more than 130 years
▼ + stars: | 2023-09-14 | by ( ) www.cnbc.com time to read: +1 min

Johnson & Johnson is signing off on a new logo. The health care giant said Thursday that it will replace the well-known signature script it has used since 1887 with a modern look that reflects its sharpened focus on pharmaceuticals and medical devices. Johnson & Johnson itself narrowed its focus to pharmaceuticals and medical devices. The signature logo was "one of the longest-used company emblems in the world," J&J declared in a 2017 website post. "Because it's easier, it almost even draws your attention to it," said Ries, who wasn't involved in the logo change.

Persons: Johnson, James Wood, Vanessa Broadhurst, J, Laura Ries, Ries, wasn't

☆ Johnson & Johnson is replacing its iconic logo
▼ + stars: | 2023-09-14 | by ( Jordan Valinsky | ) edition.cnn.com time to read: +1 min

New York CNN —Johnson & Johnson is replacing its instantly recognizable logo that’s been in use for 135 years. Although it’s a big change, shoppers likely won’t notice it since the cursive logo will still be used on its consumer products, like Band-Aid and Tylenol. Johnson & Johnson recently split into two companies — one focused on medical devices and medications and the other on consumer health products, which operates under a brand called Kenvue. The name Kenvue reflects J&J’s desire for the new consumer company identity to take a backseat to well-known brands. Still, ditching the signature J&J logo marks an end of era since the company once stated that its “one of the longest-used company emblems in the world.” The new logo will roll out over time on J&J’s medical equipment and pharmaceutical products.

Persons: New York CNN — Johnson, Johnson, James Wood Johnson, Kenvue Organizations: New, New York CNN, Unilever, Procter, Gamble Locations: New York

Johnson & Johnson is signing off on a new logo. Johnson & Johnson itself narrowed its focus to pharmaceuticals and medical devices. The signature logo was “one of the longest-used company emblems in the world,” J&J declared in a 2017 website post. “Everyone washed their baby with Johnson & Johnson baby shampoo,” she said. New Brunswick, New Jersey-based J&J also will rename its Janssen pharmaceutical segment, changing it to Johnson & Johnson Innovative Medicine.

Persons: Johnson, James Wood, ”, Vanessa Broadhurst, ” J, J, Laura Ries, Ries, wasn't Organizations: Janssen, Johnson Innovative Medicine, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: New Brunswick , New Jersey

☆ What China slowdown? Three Chinese companies making big money globally
▼ + stars: | 2023-09-10 | by ( Evelyn Cheng | ) www.cnbc.com time to read: +4 min

More Chinese companies are becoming global players. In all, BYD, state-owned SAIC and other Chinese companies gained 9% of the global electric car market in the second quarter, up from 5% in the second quarter, Counterpoint Research said. That's on top of the companies' share in the domestic Chinese market — the largest globally for autos. For the full year, XCMG has an export sales growth target of 50% growth, UBS stock analyst Phyllis Wang and a team said in a Sept. 4 note. Chinese companies have been trying to "go global" for years, with tacit encouragement from Beijing.

Persons: Lei Meng, That's, Xiao Feng, BYD, UBS's Meng, XCMG, Phyllis Wang, Mingyang, JPMorgan's Helen Zhu, — CNBC's Michael Bloom Organizations: Car, UBS Securities, China Equity, SAIC, Research, Hong, Toyota, General Motors, Britannica ., Xuzhou Construction Machinery, Central, UBS, Beijing ., JPMorgan Locations: Hong Kong, Britannica, China, Shenzhen, Xuzhou, West Asia, North Africa, Central America, Europe, Central Asia, North America, Beijing, Beijing . State, Shanghai

President Joe Biden's administration has said it plans to appeal the 5th Circuit's decision as well. The 5th Circuit's decision partially sided with the anti-abortion groups and doctors who challenged mifepristone. In April, the Supreme Court granted emergency requests by the Justice Department and the pill's manufacturer Danco Laboratories to put on hold Kacsmaryk's order while litigation continued. Mifepristone is taken with another drug called misoprostol to perform medication abortion, which accounts for more than half of all U.S. abortions. Since last year's Supreme Court decision, at least 14 U.S. states have put in place outright abortion bans while many others prohibit abortion after a certain length of pregnancy.

Persons: Evelyn Hockstein, mifepristone, Joe Biden's, Jessica Ellsworth, Circuit upended, Matthew Kacsmaryk, Roe, Wade, Andrew Chung, Will Dunham Organizations: Alamo Women's, REUTERS, U.S, Supreme, Danco Laboratories, New, Circuit, U.S . Food, Drug Administration, FDA, Justice Department, mifepristone, Republican, Alliance for Hippocratic Medicine, Defending, Thomson Locations: Carbondale , Illinois, U.S, New Orleans, Amarillo , Texas, New York

☆ Illumina names new CEO months after Icahn proxy fight over Grail deal
▼ + stars: | 2023-09-05 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Illumina 's board on Tuesday named Jacob Thaysen the DNA sequencing company's new CEO as it tries to rebound from a grinding dispute over its acquisition of cancer test developer Grail. Thaysen, a 48-year-old longtime executive at medical devices firm Agilent , will step in as CEO on Sept. 25. His nomination comes months after a bitter proxy fight with activist investor Carl Icahn ended with Illumina's former CEO Francis deSouza resigning despite securing enough votes to stay. "Jacob's unique combination of deep technological and commercial experience will be a great addition to Illumina," Stephen MacMillan, the chair of Illumina's board, said in the release. Thaysen will take over for Charles Dadswell, who has been serving as Illumina's interim CEO since June.

Persons: Illumina, Jacob Thaysen, Carl Icahn, Francis deSouza, Icahn, Thaysen, Stephen MacMillan, Charles Dadswell, Dadswell Organizations: Union, European Commission, U.S . Federal Trade Commission, Illumina Locations: Illumina, San Diego , California, U.S, Agilent

☆ Daily Blackouts Strain a Poor Spanish Neighborhood. Is Marijuana to Blame?
▼ + stars: | 2023-09-04 | by ( Constant Méheut | More About Constant Méheut | ) www.nytimes.com time to read: +1 min

On a recent morning, Ángel Ortiz Rodríguez was slumped on a sofa in his apartment in Granada, in southern Spain, a tangle of breathing tubes protruding from his nose. Since Mr. Ortiz had a heart attack a few years ago, his life has depended on an electronic breathing machine. Daily blackouts plague the 25,000 inhabitants in this poor district of northern Granada. The blackouts have been a part of life here for more than a decade, but they have grown markedly worse in recent years. Marijuana growers, the company says, illegally connect to the grid and overwhelm it because of the powerful lights and air-conditioning the plants need.

Persons: Ángel Ortiz Rodríguez, Ortiz, Rosa Martin Piñedo, ” Organizations: Food Locations: Granada, Spain, Marijuana

☆ J&J forecasts 12.5% growth in 2023 profit after Kenvue spinoff
▼ + stars: | 2023-08-30 | by ( ) www.reuters.com time to read: +1 min

Johnson & Johnson company offices are shown in Irvine, California, U.S., October 14, 2020. REUTERS/Mike Blake Acquire Licensing RightsAug 30 (Reuters) - Johnson & Johnson (JNJ.N) on Wednesday forecast 12.5% growth in its annual adjusted profit after completing the separation of consumer health company Kenvue (KVUE.N) . J&J also said it would present its consumer health business as discontinued operations and record a gain of $20 billion in the third quarter as a result of the spinoff. It expects 2023 adjusted reported earnings per share of $10.00 - $10.10, 12.5% higher at the midpoint compared with 2022. Kenvue, which debuted on the New York Stock Exchange in May, has a market capitalization of about $78.9 billion.

Persons: Johnson, Mike Blake, J, Kenvue, Manas Mishra, Devika Organizations: Johnson, REUTERS, New York Stock Exchange, Thomson Locations: Irvine , California, U.S, Bengaluru

☆ 30 dividend-paying stocks in solid sectors with upside outside the AI hype, according to a 30-year fund manager
▼ + stars: | 2023-08-27 | by ( Laila Maidan | ) www.businessinsider.com time to read: +6 min

Similar companies within the healthcare sector in his portfolio include Abbott Laboratories (ABT), which pays out a 1.95% dividend yield. Additionally, it offers a 2.35% dividend yield. Within the defense sector, he also likes Lockheed Martin (LMT), which pays a dividend yield of 2.64%. It pays out a 2.19% dividend yield plus a profit and losses payout at the end of the year. It has a 2.85% dividend yield and has increased its payout by about 8 to 10% a year, he said.

Persons: Max Wasserman, He's, Wasserman, overvalued, That's, Johnson, There's, Lockheed Martin Organizations: Miramar Capital LLC, Nasdaq, Broadcom, Microsoft, Company, NAPA Auto, Parts, Abbott Laboratories, Merck & Co, Dynamics, Group, PepsiCo Locations: Northbrook , Illinois, NAPA

☆ Nvidia's blowout results are exciting analysts so much, one of them even said the AI chipmaker will be 'most important company to civilization'
▼ + stars: | 2023-08-24 | by ( Huileng Tan | ) www.businessinsider.com time to read: +2 min

AI chipmaker Nvidia posted record second-quarter revenues of $13.51 billion. One jubilant analyst made a bold call: He thinks Nvidia will be the "most important company to civilization" in the next decade. Even Daniel Ives, an analyst at Wedbush Securities, gushed in a tweet: "It's all about AI demand and use cases. "AI needs specialized chips to run on, and trillions worth of processing chips will be up for replacement through this decade." Dessai added there are other opportunities for AI chips as they eventually make their way into other products including smartphones, laptops, cars, and medical devices.

Persons: Angelo Zino, Daniel Ives, Dessai Organizations: Nvidia, Service, Yahoo Finance, Wedbush Securities, gushed, Tejas, Global Locations: Wall, Silicon

Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. Medtronic, which makes pacemakers, catheters and other tools used in heart and gastrointestinal surgeries, joins rivals, including Abbott Laboratories (ABT.N), Stryker (SYK.N) and Boston Scientific (BSX.N), on benefiting from a rise in non-urgent surgeries. CEO Geoff Martha said trends pointed to a recovery in surgical volumes as some procedures returned to stronger than pre-pandemic levels. Whereas, revenue from its medical surgical unit rose 5.5% to $2.04 billion. Medtronic also said that it was expecting to split its patient monitoring and respiratory interventions businesses in the first half of fiscal 2025.

Persons: Dado Ruvic, Stryker, Geoff Martha, It's, Martha, Edward Jones, John Boylan, Medtronic, Bhanvi Satija, Christy Santhosh, Shweta Agarwal Organizations: REUTERS, Abbott, Abbott Laboratories, Boston, Thomson Locations: Dublin, Bengaluru

☆ Medtronic raises forecast as demand for heart devices powers upbeat results
▼ + stars: | 2023-08-22 | by ( ) www.reuters.com time to read: +2 min

REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsAug 22 (Reuters) - Medtronic (MDT.N) on Tuesday raised its annual profit forecast, after beating first-quarter estimates on higher demand for its medical devices used in heart and gastrointestinal surgeries. A recovery in non-urgent procedures and easing staffing shortages following a decline in COVID-19 cases has boosted the demand for medical devices. Sales at Medtronic's heart devices unit, its biggest revenue driver, increased 5.5% to $2.85 billion for the first quarter, above analysts' estimates of $2.78 billion. Revenue for the quarter rose 4.5% to $7.70 billion, topping analysts' average estimate of $7.57 billion. Its adjusted profit of $1.20 per share for the quarter ended July 28 beat estimates of $1.11 per share.

Persons: Dado Ruvic, Medtronic, Stryker, Bhanvi Satija, Christy Santhosh, Shweta Agarwal Organizations: REUTERS, Abbott Laboratories, Boston, Revenue, Thomson Locations: COVID, Dublin, Bengaluru

☆ Amazon Pharmacy automates discounts to help insulin patients get pledged prices
▼ + stars: | 2023-08-15 | by ( Patrick Wingrove | ) www.reuters.com time to read: +3 min

Aug 15 (Reuters) - Amazon.com (AMZN.O) said on Tuesday its online pharmacy will automatically apply manufacturer-sponsored coupons to more than 15 insulin and diabetes medicines to help patients access discounts pledged by the drug industry. Vin Gupta, Amazon Pharmacy's Chief Medical Officer, said the report highlighted the need to make it easier for patients to get their insulin at the lowest possible prices. Amazon Pharmacy will also automatically apply available discounts to diabetes-related medical devices from manufacturers Dexcom and Insulet, including continuous glucose monitors and pumps, as well as to other cardiometabolic medicines such as Novo's powerful weight-loss drug Wegovy. American Diabetes Association Chief Executive Officer Charles Henderson said Amazon's automated discounting would help the 37 million Americans with diabetes more easily access the treatments they need. So, we're going to create options that gives them access to these medications," Amazon Pharmacy Vice President John Love told Reuters.

Persons: Eli Lilly, Lilly, Elizabeth Warren, Vin Gupta, Wegovy, Charles Henderson, John Love, Patrick Wingrove, Sandra Maler Organizations: Amazon Pharmacy, Novo Nordisk, Sanofi, Amazon, Congress, American Diabetes Association, Walgreens, Reuters, Thomson Locations: New York

☆ China’s sitting on a goldmine of genetic data – and it doesn’t want to share
▼ + stars: | 2023-08-11 | by ( Jessie Yeung | ) edition.cnn.com time to read: +14 min

The national survey and restrictions on foreign access are part of new regulations on China’s genetic resources, which came into effect in July. The national genetic surveyBiobanking in China – meaning the collection of biological samples – is still “very fragmented,” and in an “embryonic stage,” said Zhang. But these concerns aren’t new – and the national genetic survey seems to be geared more toward scientific research than other purposes, several experts agreed. But China has another motive, too: establishing what some experts call “genomic sovereignty,” meaning full control of the genetic material within their country. While many other countries also have laws regulating the use and transfer of their population’s genetic material, few are as strict as China’s.

Persons: Guang Niu, ”, Joy Y, Zhang, you’re, Wei Liang, ICHPL, Anna Puglisi, Puglisi, States –, Katherine Wang, ” –, Wang, “, Sun, Xi Jinping, Jiankui, Anthony Wallace, ” Zhang Organizations: Hong Kong CNN, Central South University, Centre for Global Science, biosciences, Shanxi Province Reproductive Science, Communist Party, Georgetown’s Center for Security, Emerging Technology, Gray, Group, CNN, Ministry of Science, Technology, National Health Service, National Institutes of Health, NIH Locations: Hong Kong, China, Changsha, Shanxi Province, Taiyuan, States, “, Wuhan, Xinijang, Xinjiang, Beijing, AFP, Harvard

☆ As weight loss drug stocks rallied on a landmark study, these stocks were over sold, analysts say
▼ + stars: | 2023-08-11 | by ( Christina Cheddar Berk | ) www.cnbc.com time to read: +8 min

However, the pharmaceutical companies are making the case that weight loss can improve health, and possibly lower health-care costs over time. But analysts have said the news isn't all bad for such stocks, and many were fell too low on Tuesday. Deutsche Bank analyst Imron Zafar estimated Thursday that bariatric surgery accounts for about 5% of Intuitive Surgical's U.S. robotic surgery business, but has been driving much of the company's growth. Some of the surgeons Zafar spoke with said any drop off in bariatric surgery was likely to be offset by increased use of the robot for other procedures. But they expect the drugs will remain necessary because GLP-1 drugs have yet to show they improve fibrosis, which is associated with NASH.

Persons: nonalcoholic steatohepatitis, NASH, Abbott, Robbie Marcus, Marcus, Marcus doesn't, Goldman Sachs, Goldman, Stryker, Smith, Zimmer Biomet, Bariatric, Imron Zafar, Zafar Organizations: Novo Nordisk, Abbott Laboratories, CNBC, JPMorgan, Companies, Inspire Medical Systems, Resmed, Philips, Nephew, Deutsche Bank, Madrigal Pharmaceuticals, Sagimet Biosciences, Akero Therapeutics, Terns Pharmaceuticals, Viking Therapeutics, Madrigal Locations: U.S

☆ Medical device maker Zimmer Biomet lifts profit forecast as surgeries rebound
▼ + stars: | 2023-08-01 | by ( ) www.reuters.com time to read: +1 min

Aug 1 (Reuters) - Zimmer Biomet Holdings Inc (ZBH.N) on Tuesday raised its full-year profit forecast, anticipating demand to hold up for its medical devices following a rebound in knee and hip replacement procedures. Abbott Laboratories (ABT.N) attributed its strong quarter to hospitals addressing bottlenecks from the pandemic while Johnson & Johnson (JNJ.N) said it expected to top profit estimates with surgeries bouncing back. The company now expects full-year profit of $7.47 to $7.57 per share, compared with its previous forecast of $7.40 to $7.50. The Indiana-based company's second-quarter revenue rose nearly 5% to $1.87 billion, beating analysts' estimates of $1.83 billion. Zimmer also expects reported revenue to grow between 6.5% and 7% this year, compared to its prior forecast of between 5% and 6%.

Persons: Zimmer, Johnson, Jeff Johnson, Mariam Sunny, Sriraj Organizations: Zimmer Biomet Holdings, Abbott Laboratories, Baird Equity, Thomson Locations: Indiana, Bengaluru

Search resuls for: "Medical Devices"

25 mentions found